Exact Mass: 218.1482

Exact Mass Matches: 218.1482

Found 153 metabolites which its exact mass value is equals to given mass value 218.1482, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Methoxydimethyltryptamine

[2-(5-methoxy-1H-indol-3-yl)ethyl]dimethylamine

C13H18N2O (218.1419)


5-Methoxydimethyltryptamine, like all methoxydimethyltryptamines is a compound that contain the biogenic monoamine tryptamine and is substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia. They are formed as metabolites of serotonin (5-hydroxytryptamine) or tryptamine by the enzyme indolethylamine N-methyltransferase (INMT). The physiological significance of the N-methylating pathway of indoleamine metabolism, and of the methylated end products, is unknown. Because of the known psychotropic properties of the dimethylated amines, their possible involvement in the chemical pathogenesis of mental disorders has received wide interest. The hallucinogenic actions of the methylated indoleamines, like those of LSD, are believed to be mediated through the 5HT2 receptor. (PMID 11763413). 5-Methoxydimethyltryptamine, like all Methoxydimethyltryptamines is a compound that contain the biogenic monoamine tryptamine and is substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia. (PubChem) C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist KEIO_ID M103; [MS2] KO009040 KEIO_ID M103

   

Aclatonium

Aclatonium

C10H20NO4+ (218.1392)


C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist

   

N-despropyl ropinirole

4-[2-(propylamino)ethyl]-2,3-dihydro-1H-indol-2-one

C13H18N2O (218.1419)


N-despropyl ropinirole is a metabolite of ropinirole. Ropinirole (INN; trade names Requip, Ropark, Adartrel) is a non-ergoline dopamine agonist. It is manufactured by GlaxoSmithKline (GSK), Cipla and Sun Pharmaceutical. It is used in the treatment of Parkinsons disease. Ropinirole is one of three medications approved by the FDA to treat Restless Leg Syndrome, the other two being pramipexole (Mirapex) and gabapentin enacarbil (Horizant). The discovery of the drugs utility in RLS has been used as a successful example of drug repurposing. (Wikipedia)

   

(+)-Eseroline

Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, (3aS-cis)-

C13H18N2O (218.1419)


   

2-(Phenylamino)-1-(piperidin-1-yl)ethan-1-one

2-(Phenylamino)-1-(piperidin-1-yl)ethan-1-one

C13H18N2O (218.1419)


   

2,3-Dihydroxypropyl octanoate

(+-)-2,3-Dihydroxypropyl octanoic acid

C11H22O4 (218.1518)


C78276 - Agent Affecting Digestive System or Metabolism

   

N-Desethyl Milnacipran

2-(Aminomethyl)-N-ethyl-1-phenylcyclopropane-1-carboximidate

C13H18N2O (218.1419)


   

Richter

2-Amino-N-(1,2,3,4-tetrahydronaphthalen-2-yl)propanimidate

C13H18N2O (218.1419)


   

N-Ethylcytisine

(-)-N-Ethylcytisine

C13H18N2O (218.1419)


   

4-methoxy DMT

4-methoxy DMT

C13H18N2O (218.1419)


   

4-Hydroxy-N-methyl-N-ethyltryptamine

4-Hydroxy-N-methyl-N-ethyltryptamine

C13H18N2O (218.1419)


   

5-Methoxy-alpha-ethyltryptamine

5-Methoxy-alpha-ethyltryptamine

C13H18N2O (218.1419)


   

2-Phenyl-2-(piperidin-2-yl)acetamide

2-Phenyl-2-(piperidin-2-yl)acetamide

C13H18N2O (218.1419)


   

SCHEMBL150459

SCHEMBL150459

C13H18N2O (218.1419)


   

N-p-Cinnamoylputrescine

N-p-Cinnamoylputrescine

C13H18N2O (218.1419)


   
   

Nornicotine, N-butanoyl

Nornicotine, N-butanoyl

C13H18N2O (218.1419)


   

2-chlorododec-2-en-1-ol

2-chlorododec-2-en-1-ol

C12H23ClO (218.1437)


   

Monocaprylin

2,3-Dihydroxypropyl octanoate

C11H22O4 (218.1518)


C78276 - Agent Affecting Digestive System or Metabolism

   

1,8-Dimethyl-3a-methoxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole

1,8-Dimethyl-3a-methoxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole

C13H18N2O (218.1419)


   
   

6-hydroxyhexyl 5-hydroxypentanoate

6-hydroxyhexyl 5-hydroxypentanoate

C11H22O4 (218.1518)


   

Eseroline

Eseroline

C13H18N2O (218.1419)


A pyrroloindole that is 1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole substituted by methyl groups at positions 1, 3a and 8 and a hydroxy group at position 5. It is a metabolite of physostigmine and causes neuronal cell death by a mechanism involving loss of cell ATP. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3583

   

2-Phenylpiperidine-2-acetamide

2-Phenyl-2-(piperidin-2-yl)acetamide

C13H18N2O (218.1419)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3584

   

(-)-Eseroline

(-)-Eseroline

C13H18N2O (218.1419)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.272

   

Cinnamoyl putrescin

Cinnamoyl putrescin

C13H18N2O (218.1419)


Annotation level-3

   

1-carboxy-1-(trimethyl-l4-azaneyl)-4-ureidobutan-1-ylium

1-carboxy-1-(trimethyl-l4-azaneyl)-4-ureidobutan-1-ylium

C9H20N3O3 (218.1505)


   

2-((3-ethoxy-3-oxopropanoyl)oxy)-N,N,N-trimethylethan-1-aminium

2-((3-ethoxy-3-oxopropanoyl)oxy)-N,N,N-trimethylethan-1-aminium

[C10H20NO4]+ (218.1392)


   

4-(2-(PROPYLAMINO)ETHYL)INDOLIN-2-ONE

4-[2-(Propylamino)ethyl]-1,3-dihydro-2H-indol-2-one

C13H18N2O (218.1419)


   

10,11-Difluoro-8E,10E-dodecadien-1-ol

10,11-Difluoro-8E,10E-dodecadien-1-ol

C12H20F2O (218.1482)


   

8,9-Difluoro-8E,10E-dodecadien-1-ol

8,9-Difluoro-8E,10E-dodecadien-1-ol

C12H20F2O (218.1482)


   

FA 11:0;O2

Nonanoic acid, 9,9-dimethoxy-

C11H22O4 (218.1518)


   

10,11-Difluoro-8E,10E-dodecadien-1-ol

10,11-Difluoro-8E,10E-dodecadien-1-ol

C12H20OF2 (218.1482)


   

8,9-Difluoro-8E,10E-dodecadien-1-ol

8,9-Difluoro-8E,10E-dodecadien-1-ol

C12H20OF2 (218.1482)


   

2,5-dimethyl-N-phenyl-pyrrolidine-1-carboxamide

2,5-dimethyl-N-phenyl-pyrrolidine-1-carboxamide

C13H18N2O (218.1419)


   

4-(4-ethylpiperazin-1-yl)benzaldehyde

4-(4-ethylpiperazin-1-yl)benzaldehyde

C13H18N2O (218.1419)


   

1-(3-DIMETHYLAMINO-PROPYL)-1H-BENZOIMIDAZOL-2-YLAMINE

1-(3-DIMETHYLAMINO-PROPYL)-1H-BENZOIMIDAZOL-2-YLAMINE

C12H18N4 (218.1531)


   

1-[4-(PIPERIDIN-1-YLCARBONYL)PHENYL]METHANAMINE

1-[4-(PIPERIDIN-1-YLCARBONYL)PHENYL]METHANAMINE

C13H18N2O (218.1419)


   

3-(Diethoxymethyl)-2-ethoxytetrahydrofuran

3-(Diethoxymethyl)-2-ethoxytetrahydrofuran

C11H22O4 (218.1518)


   

2-amino-n-cyclohexylbenzamide

2-amino-n-cyclohexylbenzamide

C13H18N2O (218.1419)


   

3-(1,2,4-triazol-1-yl)adamantan-1-amine

3-(1,2,4-triazol-1-yl)adamantan-1-amine

C12H18N4 (218.1531)


   

1-(2-AMINO-1,3-THIAZOL-4-YL)ETHANONE

1-(2-AMINO-1,3-THIAZOL-4-YL)ETHANONE

C13H18N2O (218.1419)


   

1-[4-(4-methylpiperazino)phenyl]-1-ethanone

1-[4-(4-methylpiperazino)phenyl]-1-ethanone

C13H18N2O (218.1419)


   

3-Amino-3-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester

3-Amino-3-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester

C10H19FN2O2 (218.143)


   

3-((4-METHYLPIPERAZIN-1-YL)METHYL)BENZALDEHYDE

3-((4-METHYLPIPERAZIN-1-YL)METHYL)BENZALDEHYDE

C13H18N2O (218.1419)


   

1-(3-acetyl-2,4-dihydroxy-6-methoxyphenyl)ethan-1-one

1-(3-acetyl-2,4-dihydroxy-6-methoxyphenyl)ethan-1-one

C13H18N2O (218.1419)


   

1-Benzylpiperidine-4-carboxyamide

1-Benzylpiperidine-4-carboxyamide

C13H18N2O (218.1419)


   

4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE

4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE

C13H18N2O (218.1419)


   

N-(5-AMINO-2-METHOXYPHENYL)-2-METHOXYACETAMIDE

N-(5-AMINO-2-METHOXYPHENYL)-2-METHOXYACETAMIDE

C13H18N2O (218.1419)


   

(S)-(-)-1,2,4-BUTANETRIOL

(S)-(-)-1,2,4-BUTANETRIOL

C13H18N2O (218.1419)


   

1-Phenyl-3-(1-piperazinyl)-1-propanone

1-Phenyl-3-(1-piperazinyl)-1-propanone

C13H18N2O (218.1419)


   

(1S,4S)-(+)-2-(2-CHLORO-BENZYL)-2,5-DIAZA-BICYCLO[2.2.1]HEPTANEDIHYDROCHLORIDE

(1S,4S)-(+)-2-(2-CHLORO-BENZYL)-2,5-DIAZA-BICYCLO[2.2.1]HEPTANEDIHYDROCHLORIDE

C13H18N2O (218.1419)


   

N-BENZYLPIPERIDINE-4-CARBOXAMIDE HYDROCHLORIDE

N-BENZYLPIPERIDINE-4-CARBOXAMIDE HYDROCHLORIDE

C13H18N2O (218.1419)


   

Benzonitrile,4-[2-(diethylamino)ethoxy]-

Benzonitrile,4-[2-(diethylamino)ethoxy]-

C13H18N2O (218.1419)


   

(3S)-3-Amino-1-benzyl-2-azepanone

(3S)-3-Amino-1-benzyl-2-azepanone

C13H18N2O (218.1419)


   

5-ADAMANTAN-1-YL-4H-1,2,4-TRIAZOL-3-YLAMINE

5-ADAMANTAN-1-YL-4H-1,2,4-TRIAZOL-3-YLAMINE

C12H18N4 (218.1531)


   

N-(1-Benzyl-3-pyrrolidinyl)acetamide

N-(1-Benzyl-3-pyrrolidinyl)acetamide

C13H18N2O (218.1419)


   

2-[5-ethyl-5-(hydroxymethyl)-1,3-dioxan-2-yl]-2-methylpropan-1-ol

2-[5-ethyl-5-(hydroxymethyl)-1,3-dioxan-2-yl]-2-methylpropan-1-ol

C11H22O4 (218.1518)


   

1-Benzyl-5-(aminomethyl)piperidin-2-one

1-Benzyl-5-(aminomethyl)piperidin-2-one

C13H18N2O (218.1419)


   

4-BROMOTHIOBENZAMIDE

4-BROMOTHIOBENZAMIDE

C13H18N2O (218.1419)


   

N-(3-AMINOPHENYL)CYCLOPENTANECARBOXAMIDE

N-(3-AMINOPHENYL)CYCLOPENTANECARBOXAMIDE

C13H18N2O (218.1419)


   

3-CHLORO-4-FLUOROBENZENESULFONAMIDE

3-CHLORO-4-FLUOROBENZENESULFONAMIDE

C13H18N2O (218.1419)


   

2,3-DIBROMOPROPIONICACIDMETHYLESTER

2,3-DIBROMOPROPIONICACIDMETHYLESTER

C13H18N2O (218.1419)


   

4,4,5,5-Tetramethyl-2-(m-tolyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(m-tolyl)-1,3,2-dioxaborolane

C13H19BO2 (218.1478)


   

(butan-2-olato)bis(propan-2-olato)aluminium

(butan-2-olato)bis(propan-2-olato)aluminium

C10H23AlO3 (218.1463)


   

2H-Azepin-2-one, hexahydro-3-[(phenylmethyl)amino]-, (3R)

2H-Azepin-2-one, hexahydro-3-[(phenylmethyl)amino]-, (3R)

C13H18N2O (218.1419)


   

(4S)-4-tert-butyl-2-(6-methylpyridin-2-yl)-4,5-dihydro-1,3-oxazole

(4S)-4-tert-butyl-2-(6-methylpyridin-2-yl)-4,5-dihydro-1,3-oxazole

C13H18N2O (218.1419)


   

N-(4-Aminophenyl)cyclohexanecarboxamide

N-(4-Aminophenyl)cyclohexanecarboxamide

C13H18N2O (218.1419)


   

4-(2-ETHYLPHENOXY)ANILINE

4-(2-ETHYLPHENOXY)ANILINE

C13H18N2O (218.1419)


   

4-Amino-N-cyclohexylbenzamide

4-Amino-N-cyclohexylbenzamide

C13H18N2O (218.1419)


   

N-Methyl-4-(4-piperidinyl)benzamide

N-Methyl-4-(4-piperidinyl)benzamide

C13H18N2O (218.1419)


   

1-(3,4-DIHYDRO-2H-[1,8]NAPHTHYRIDIN-1-YL)-2,2-DIMETHYL-PROPAN-1-ONE

1-(3,4-DIHYDRO-2H-[1,8]NAPHTHYRIDIN-1-YL)-2,2-DIMETHYL-PROPAN-1-ONE

C13H18N2O (218.1419)


   

2-Phenyl-2-(1-piperidinyl)acetamide

2-Phenyl-2-(1-piperidinyl)acetamide

C13H18N2O (218.1419)


   

Fenoxazoline

Fenoxazoline

C13H18N2O (218.1419)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

N-(4-phenylpiperidin-4-yl)acetamide

N-(4-phenylpiperidin-4-yl)acetamide

C13H18N2O (218.1419)


   

2-Oxa-6-azaspiro[3.4]octan-8-amine, 6-(phenylmethyl)-

2-Oxa-6-azaspiro[3.4]octan-8-amine, 6-(phenylmethyl)-

C13H18N2O (218.1419)


   

(3R)-3-Amino-1-benzyl-2-azepanone

(3R)-3-Amino-1-benzyl-2-azepanone

C13H18N2O (218.1419)


   

(S)-5-BENZYL-2,2,3-TRIMETHYLIMIDAZOLIDIN-4-ONE

(S)-5-BENZYL-2,2,3-TRIMETHYLIMIDAZOLIDIN-4-ONE

C13H18N2O (218.1419)


   

4,4,5,5-Tetramethyl-2-(2-methylphenyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(2-methylphenyl)-1,3,2-dioxaborolane

C13H19BO2 (218.1478)


   

Cyclopropanamine, 1-[3-(4-morpholinyl)phenyl]

Cyclopropanamine, 1-[3-(4-morpholinyl)phenyl]

C13H18N2O (218.1419)


   

2-(4-ethylpiperazin-1-yl)benzaldehyde

2-(4-ethylpiperazin-1-yl)benzaldehyde

C13H18N2O (218.1419)


   

3-[2-(Ethyl-Methyl-Amino)-Ethyl]-1H-Indol-4-Ol

3-[2-(Ethyl-Methyl-Amino)-Ethyl]-1H-Indol-4-Ol

C13H18N2O (218.1419)


   

4-Amino-2-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl

4-Amino-2-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl

C10H19FN2O2 (218.143)


   

1,3-Di-tert-butyl-1,3,2-diazaphospholidine 2-Oxide

1,3-Di-tert-butyl-1,3,2-diazaphospholidine 2-Oxide

C10H23N2OP (218.1548)


   

Lauroyl chloride

Dodecanoyl chloride

C12H23ClO (218.1437)


   

(4-AMINO-BENZYL)-UREA

(4-AMINO-BENZYL)-UREA

C13H18N2O (218.1419)


   

N-(3-ALLYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE

N-(3-ALLYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE

C13H18N2O (218.1419)


   

5-methoxy-2-methylgramine

5-methoxy-2-methylgramine

C13H18N2O (218.1419)


   

1-cycloheptylpiperazine,hydrochloride

1-cycloheptylpiperazine,hydrochloride

C11H23ClN2 (218.155)


   

N-((R)-1-Benzylpyrrolidin-3-yl)acetamide

N-((R)-1-Benzylpyrrolidin-3-yl)acetamide

C13H18N2O (218.1419)


   

5-(Methylsulfonyl)-2-pyridinecarboxylic Acid

5-(Methylsulfonyl)-2-pyridinecarboxylic Acid

C13H18N2O (218.1419)


   

1-(7-amino-4,4-dimethyl-1,3-dihydroisoquinolin-2-yl)ethanone

1-(7-amino-4,4-dimethyl-1,3-dihydroisoquinolin-2-yl)ethanone

C13H18N2O (218.1419)


   

N-Desethyl Milnacipran

N-Desethyl Milnacipran

C13H18N2O (218.1419)


   

(3R,4R)-tert-Butyl4-amino-3-fluoropiperidine-1-carboxylate

(3R,4R)-tert-Butyl4-amino-3-fluoropiperidine-1-carboxylate

C10H19FN2O2 (218.143)


   

5-(2-Aminoethyl)-1-benzyl-2-pyrrolidinone

5-(2-Aminoethyl)-1-benzyl-2-pyrrolidinone

C13H18N2O (218.1419)


   

10-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline

10-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline

C13H18N2O (218.1419)


   

9-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline

9-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline

C13H18N2O (218.1419)


   

1-(1,4-diazepan-1-yl)-2-phenylethanone

1-(1,4-diazepan-1-yl)-2-phenylethanone

C13H18N2O (218.1419)


   

4-[(4-methylpiperazin-1-yl)methyl]benzaldehyde

4-[(4-methylpiperazin-1-yl)methyl]benzaldehyde

C13H18N2O (218.1419)


   

Benzylboronic acid pinacol ester

Benzylboronic acid pinacol ester

C13H19BO2 (218.1478)


   

tert-butyl N-[(3R,4R)-4-fluoropiperidin-3-yl]carbamate

tert-butyl N-[(3R,4R)-4-fluoropiperidin-3-yl]carbamate

C10H19FN2O2 (218.143)


   

(3S,4R)-rel-3-(Boc-aMino)-4-fluoropiperidine

(3S,4R)-rel-3-(Boc-aMino)-4-fluoropiperidine

C10H19FN2O2 (218.143)


   

1-Methyl-4,4-bipiperidine hydrochloride

1-Methyl-4,4-bipiperidine hydrochloride

C11H23ClN2 (218.155)


   

1-[(3,4-dimethylphenyl)methyl]piperazin-2-one

1-[(3,4-dimethylphenyl)methyl]piperazin-2-one

C13H18N2O (218.1419)


   

METHYL2-PYRAZINEACETATE

METHYL2-PYRAZINEACETATE

C13H18N2O (218.1419)


   

1-(2-Ethoxyethyl)-2-ethyl-1H-benzimidazole

1-(2-Ethoxyethyl)-2-ethyl-1H-benzimidazole

C13H18N2O (218.1419)


   

2-methyl-N-phenylpiperidine-1-carboxamide

2-methyl-N-phenylpiperidine-1-carboxamide

C13H18N2O (218.1419)


   

1-PHENYL-CYCLOHEXANECARBOXYLIC ACID HYDRAZIDE

1-PHENYL-CYCLOHEXANECARBOXYLIC ACID HYDRAZIDE

C13H18N2O (218.1419)


   

3,9-Diazaspiro[5.5]undecan-2-one, 3-ethyl-, hydrochloride (1:1)

3,9-Diazaspiro[5.5]undecan-2-one, 3-ethyl-, hydrochloride (1:1)

C11H23ClN2 (218.155)


   

1-benzyl-3,5-dimethylpiperazin-2-one

1-benzyl-3,5-dimethylpiperazin-2-one

C13H18N2O (218.1419)


   

4,4,5,5-Tetramethyl-2-(p-tolyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(p-tolyl)-1,3,2-dioxaborolane

C13H19BO2 (218.1478)


   

(4-AMINO-CYCLOHEXYL)-ACETICACIDMETHYLESTER

(4-AMINO-CYCLOHEXYL)-ACETICACIDMETHYLESTER

C13H18N2O (218.1419)


   

1-[3-(4-Methyl-1-piperazinyl)phenyl]ethanone

1-[3-(4-Methyl-1-piperazinyl)phenyl]ethanone

C13H18N2O (218.1419)


   

tert-butyl 4-amino-3-fluoropiperidine-1-carboxylate

tert-butyl 4-amino-3-fluoropiperidine-1-carboxylate

C10H19FN2O2 (218.143)


   

4-PIPERIDIN-4-YLMETHYL-BENZAMIDE

4-PIPERIDIN-4-YLMETHYL-BENZAMIDE

C13H18N2O (218.1419)


   

1,1-Hexane-1,6-Diylbis(1h-Imidazole)

1,1-Hexane-1,6-Diylbis(1h-Imidazole)

C12H18N4 (218.1531)


   

(2S)-2,3-dihydroxypropyl octanoate

(2S)-2,3-dihydroxypropyl octanoate

C11H22O4 (218.1518)


   

N-Phenyl-N-4-piperidinylacetamide

N-Phenyl-N-4-piperidinylacetamide

C13H18N2O (218.1419)


   

2-methyl-N-[4-(propan-2-ylamino)phenyl]-2-propenamide

2-methyl-N-[4-(propan-2-ylamino)phenyl]-2-propenamide

C13H18N2O (218.1419)


   

9,9-dimethoxynonanoic Acid

9,9-dimethoxynonanoic Acid

C11H22O4 (218.1518)


   

MeODMT

1H-Indole-3-ethanamine, 5-methoxy-N,N-dimethyl- (9CI)

C13H18N2O (218.1419)


C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

N-Desethyl Milnacipran

2-(Aminomethyl)-N-ethyl-1-phenylcyclopropane-1-carboximidate

C13H18N2O (218.1419)


   

Propionyl-L-carnitine

Propionyl-L-carnitine

C10H20NO4+ (218.1392)


   

gamma-L-glutamylputrescinium(1+)

gamma-L-glutamylputrescinium(1+)

C9H20N3O3+ (218.1505)


Conjugate acid of gamma-L-glutamylputrescine.

   

D-Propionylcarnitine

D-Propionylcarnitine

C10H20NO4+ (218.1392)


   

3-Octanoyl-sn-glycerol

3-Octanoyl-sn-glycerol

C11H22O4 (218.1518)


   

L-alanyl-L-lysine cation

L-alanyl-L-lysine cation

C9H20N3O3+ (218.1505)


   
   

(3aS,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol

(3aS,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol

C13H18N2O (218.1419)


   

gamma-aminobutanoyl-L-ornithine

gamma-aminobutanoyl-L-ornithine

C9H20N3O3+ (218.1505)


   

3-(Propionyloxy)-4-(trimethylaminio)butanoic acid

3-(Propionyloxy)-4-(trimethylaminio)butanoic acid

C10H20NO4+ (218.1392)


   

(3R)-3,11-dihydroxyundecanoic acid

(3R)-3,11-dihydroxyundecanoic acid

C11H22O4 (218.1518)


A dihydroxy monocarboxylic acid that is 11-hydroxyundecanoic acid in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.

   

(3R,10R)-3,10-dihydroxyundecanoic acid

(3R,10R)-3,10-dihydroxyundecanoic acid

C11H22O4 (218.1518)


An (omega-1)-hydroxy fatty acid that is (10R)-10-hydroxyundecanoic acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.

   

6-(4-methylpiperidin-1-yl)-7H-purin-1-ium

6-(4-methylpiperidin-1-yl)-7H-purin-1-ium

C11H16N5+ (218.1406)


   

[(2R)-3-carboxy-2-propanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium

[(2R)-3-carboxy-2-propanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium

C10H20NO4+ (218.1392)


   

N-(4-aminobutyl)cinnamamide

N-(4-aminobutyl)cinnamamide

C13H18N2O (218.1419)


   

2-Methyl-5-methoxy-3-(beta-aminopropyl)-indole

2-Methyl-5-methoxy-3-(beta-aminopropyl)-indole

C13H18N2O (218.1419)


   

2-((3-ethoxy-3-oxopropanoyl)oxy)-N,N,N-trimethylethan-1-aminium

2-((3-ethoxy-3-oxopropanoyl)oxy)-N,N,N-trimethylethan-1-aminium

C10H20NO4+ (218.1392)


   

Dinordesoxy-9-methyl-7-methoxyeseroline

Dinordesoxy-9-methyl-7-methoxyeseroline

C13H18N2O (218.1419)


   

2-Methyl-5-methoxyhomotryptamine

2-Methyl-5-methoxyhomotryptamine

C13H18N2O (218.1419)


   

Pentyl (3S)-3-hydroxy-5-methoxypentanoate

Pentyl (3S)-3-hydroxy-5-methoxypentanoate

C11H22O4 (218.1518)


   

1-carboxy-1-(trimethyl-l4-azaneyl)-4-ureidobutan-1-ylium

1-carboxy-1-(trimethyl-l4-azaneyl)-4-ureidobutan-1-ylium

C9H20N3O3+ (218.1505)


   

5-Methoxydimethyltryptamine

N,N-Dimethyl-5-methoxytryptamine

C13H18N2O (218.1419)


C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

alpha-Phenylpiperidine-2-acetamide

2-Phenyl-2-(piperidin-2-yl)acetamide

C13H18N2O (218.1419)


   

Ala-Lys(1+)

Ala-Lys(1+)

C9H20N3O3 (218.1505)


A peptide cation obtained by deprotonation of the carboxy terminus and protonation of the side-chain amino groups and the amino terminus of Ala-Lys; major species at pH 7.3.

   

5-Methoxy-N,N-dimethyltryptamine

5-Methoxy-N,N-dimethyltryptamine

C13H18N2O (218.1419)


A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5.

   

RO5256390

RO5256390

C13H18N2O (218.1419)


RO5256390 is an agonist of trace amine-associated receptor 1 (TAAR1), a highly conserved G-protein-coupled receptor (GPCR) bound by endogenous trace amines. RO5256390 can be used to reduce multiple behavioral effects of agents of abuse through their actions on the mesocorticolimbic system[1]. RO5256390 is a modulator of monoaminergic neurotransmission, blocks psychostimulant-induced hyperactivity and produces a brain activation pattern reminiscent of the antipsychotic agent olanzapine, suggesting antipsychotic-like properties[2].

   

3a-methoxy-1,8-dimethyl-2h,3h,8ah-pyrrolo[2,3-b]indole

3a-methoxy-1,8-dimethyl-2h,3h,8ah-pyrrolo[2,3-b]indole

C13H18N2O (218.1419)


   

(2z)-2-chlorododec-2-en-1-ol

(2z)-2-chlorododec-2-en-1-ol

C12H23ClO (218.1437)


   

(3ar,8ar)-3a-methoxy-1,8-dimethyl-2h,3h,8ah-pyrrolo[2,3-b]indole

(3ar,8ar)-3a-methoxy-1,8-dimethyl-2h,3h,8ah-pyrrolo[2,3-b]indole

C13H18N2O (218.1419)


   

(1r,9s)-11-ethyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1r,9s)-11-ethyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H18N2O (218.1419)


   

n-(4-aminobutyl)-3-phenylprop-2-enimidic acid

n-(4-aminobutyl)-3-phenylprop-2-enimidic acid

C13H18N2O (218.1419)


   

11-ethyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-ethyl-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C13H18N2O (218.1419)